It has been reported that OLFM4+ cells in the urethral luminal epithelium were increased in human benign prostatic hyperplasia (BPH) and survive treatment with 5-a-reductase inhibitor (5ARI), which inhibits the conversion of testosterone to dihydrotestosterone27. This evidence concerns the gene OLFM4 and benign prostatic hyperplasia.